Contraceptive prevalence, any modern method in Spain
Spain: Contraceptive prevalence, any modern method was 59.9% in 2018. ▲ Rising
Contraceptive prevalence, any modern method in Spain, 1977–2018
Source: Household surveys, United Nations (UN), note: Household surveys, including Demographic and Health Surveys and Multiple Indicator Cluster Surveys. Largely compiled by United Nations Population Division. Measured in % of married women ages 15-49.
Analysis
The most recent figure for contraceptive prevalence, any modern method in Spain is 59.9%, measured in 2018.
The figure is down 12.3% over ten years.
Over the whole period, contraceptive prevalence, any modern method in Spain peaked at 68.3% in 2009 and was at its lowest, 18.6%, in 1977.
Spain ranks 27th of 113 countries on this measure, in the top quarter.
Contraceptive prevalence, any modern method in Spain, year by year
| Year | % of married women ages 15-49 | Change |
|---|---|---|
| 1977 | 18.6% | — |
| 1985 | 41.6% | +123.6% |
| 1995 | 67.5% | +62.3% |
| 1999 | 66.4% | -1.6% |
| 2006 | 62.2% | -6.4% |
| 2009 | 68.3% | +9.8% |
| 2018 | 59.9% | -12.3% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1970s | 18.6% | 18.6% | 18.6% | 1 |
| 1980s | 41.6% | 41.6% | 41.6% | 1 |
| 1990s | 67.0% | 66.4% | 67.5% | 2 |
| 2000s | 65.2% | 62.2% | 68.3% | 2 |
| 2010s | 59.9% | 59.9% | 59.9% | 1 |
Countries ranked near Spain
More health data for Spain
- Un projection of annual infant deaths, annual growth rate -1.82 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.2629 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,290 deaths per 1,000 people (2090)
- Number of infants who die before age 1 108 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -0.0396 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0173 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.0227 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is contraceptive prevalence, any modern method in Spain?
- Contraceptive prevalence, any modern method in Spain was 59.9% in 2018, according to Household surveys, United Nations (UN), note: Household surveys, including Demographic and Health Surveys and Multiple Indicator Cluster Surveys. Largely compiled by United Nations Population Division.
- What is the highest contraceptive prevalence, any modern method recorded in Spain?
- The highest recorded value was 68.3% in 2009.
- What is the lowest contraceptive prevalence, any modern method recorded in Spain?
- The lowest recorded value was 18.6% in 1977.
- How does Spain rank for contraceptive prevalence, any modern method?
- Spain ranks 27th out of 113 countries with data for 2018.
- Is contraceptive prevalence, any modern method rising or falling in Spain?
- Over the last ten years it is down 12.3%. The long-run trend across the full record is rising.
- Where does this Spain data come from?
- The figures come from Household surveys, United Nations (UN), note: Household surveys, including Demographic and Health Surveys and Multiple Indicator Cluster Surveys. Largely compiled by United Nations Population Division, published as part of Contraceptive prevalence, any modern method (% of married women ages 15-49). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 7 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Contraceptive prevalence, any modern method is the percentage of married women ages 15-49 who are practicing, or whose sexual partners are practicing, at least one modern method of contraception. Modern methods of contraception include female and male sterilization, oral hormonal pills, the intra-uterine device (IUD), the male condom, injectables, the implant (including Norplant), vaginal barrier methods, the female condom and emergency contraception.